Sign In
Learn bits
Health & Medicine
Mahesh

07/09/22 13:51 PM IST

India's first intranasal Covid vaccine by Bharat Biotech gets DCGI approval

In News 
  • India's first intranasal Covid vaccine by Bharat Biotech received DCGI approval for primary immunization against the infection for people above the age of 18.
About Intranasal Vaccine 
  • The intranasal vaccine for COVID-19 by Bharat Biotech is first of its kind needle-free vaccine.
  • Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine approved by @CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for restricted use in emergency situation.
iNCOVACC
  • The iNCOVACC is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilized spike protein.
  • This vaccine candidate was evaluated in phase I, II and III clinical trials with successful results.
  • This vaccine has been specifically formulated to allow intranasal delivery through nasal drops.
  • The nasal delivery system has been designed and developed to be cost-effective in low and middle-income countries.
  • The intranasal vaccine is a heterologous booster dose.
Source- Live Mint 

More Related Current Affairs View All

17 Sep

Reasons Behind the heavy rain in Uttarakhand, Himachal

'Dehradun and several other districts in Uttarakhand have experienced very heavy rainfall over the past few days, triggering landslides in multiple areas and causing rivers to swel

Read More

08 Sep

Rajasthan’s coaching centre Bill

'The Rajasthan Coaching Centres (Control and Regulation) Bill, 2025, is a significant piece of legislation passed by the Rajasthan Assembly to regulate and oversee the state's burg

Read More

28 Aug

IADT-1

'Recently, the Indian Space Research Organisation (ISRO) successfully carried out its first Integrated Air Drop Test (IADT-1), a crucial milestone in the preparation for the countr

Read More

India’s First Ai-Driven Magazine Generator

Generate Your Custom Current Affairs Magazine using our AI in just 3 steps